Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 0093-5058

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 0093-5058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Image 1)

Chemical structure of Atorvastatin Calcium dihydrate, displaying the molecular arrangement including aromatic rings, hydroxyl groups, and calcium ion with water molecules indicated.*

FDA Label Image

Figure 1 (Image 2)

A line chart showing cumulative incidence percentages over time in years for Atorvastatin versus placebo groups. The chart compares the cumulative incidence of an unspecified outcome, with Atorvastatin represented by a solid line and placebo by a dashed line. The graph includes a hazard ratio (HR) of 0.64 with a confidence interval of 0.50 to 0.83 and a p-value of 0.0005, indicating statistical analysis results.*

FDA Label Image

Figure 2 (Image 3)

A line graph comparing the cumulative hazard percentage over time for Atorvastatin versus placebo. The x-axis shows time to first primary endpoint over four years, and the y-axis shows cumulative hazard percentage. The graph includes hazard ratio and p-value statistics.*

FDA Label Image

Figure 3 (Image 4)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time between Atorvastatin 10 mg and 80 mg doses. The x-axis represents time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows the percentage of subjects experiencing the event (0 to 0.2%). Two lines illustrate event occurrence trends for Atorvastatin 10 mg (dashed line) and Atorvastatin 80 mg (solid line), with a hazard ratio (HR) of 0.78 and P-value of 0.0002 indicated on the graph.*

FDA Label Image

10 mg Usp (Image 5)

Label for Atorvastatin Calcium Tablets USP 10 mg, film-coated oral tablets packaged in a container of 90 tablets. The label includes the NDC 0093-5056-98 and highlights dispensing instructions along with the manufacturer Teva Pharmaceuticals USA, Inc. It advises pharmacists to dispense with the attached patient information leaflet and warns to keep out of reach of children.*

FDA Label Image

20mg Usp (Image 6)

Atorvastatin Calcium Tablets USP 20 mg film-coated oral tablets by Teva Pharmaceuticals USA, Inc. The label states 90 tablets per package and includes instructions to dispense with an attached patient information leaflet. The label features serialization coding and barcode details.*

FDA Label Image

40 mg Usp (Image 7)

Atorvastatin Calcium Tablets USP 40 mg bottle label from Teva Pharmaceuticals USA, Inc. The label specifies 90 film-coated tablets for oral use, includes the NDC 0093-5058, and instructs dispensing with an attached patient information leaflet. The label includes serialization coding area, storage instructions, and manufacturer details.*

FDA Label Image

80 mg Usp (Image 8)

Atorvastatin Calcium Tablets USP 80 mg film-coated tablet label from Teva Pharmaceuticals USA, Inc. The label includes the NDC 0093-5057-98 and indicates a package size of 90 tablets. Storage instructions specify 20° to 25°C (68° to 77°F) with protection from light and moisture. The label states Rx only and advises dispensing with an attached patient information leaflet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.